UPDF AI

3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.

G. Deeb,M. Reardon,27 Authors,CoreValve U.S. Pivotal High Risk Trial Clinical Investigators

2016 · DOI: 10.1016/j.jacc.2016.03.506
Journal of the American College of Cardiology · 315 Citations

TLDR

Patients with severe aortic stenosis at increased risk for surgery had improved 3-year clinical outcomes after TAVR compared with surgery, and aorti valve hemodynamics were more favorable in TAVr patients without differences in structural valve deterioration.